Alpha 2.0
Login Register
» Articles » PMID: 37030318

Differential Serum Neutralisation of Omicron Sublineages in Patients Receiving Prophylaxis with Tixagevimab-cilgavimab

Overview
Journal Lancet Infect Dis
Specialty Infectious Diseases
Date 2023 Apr 8
PMID 37030318
Authors
Javier T Solera
Berta G Arbol
Victor H Ferreira
Alexandra Kurtesi
Queenie Hu
Matthew Ierullo
Adriana Valverde-Zuniga
Ismail Raslan
Asma Nasir
Clara Grizales
W Rod Hardy
Vathany Kulasingam
Anne-Claude Gingras
Atul Humar
Deepali Kumar
Affiliations
Soon will be listed here.
Citing Articles

Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study.

Boongird S, Srithongkul T, Sethakarun S, Bruminhent J, Kiertiburanakul S, Nongnuch A Clin Kidney J. 2024; 17(11):sfae309.

PMID: 39539359 PMC: 11558061. DOI: 10.1093/ckj/sfae309.

Efficacy of Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against Infection from SARS-CoV-2 and Severe COVID-19 among Heavily Immunocompromised Patients: A Single-Center, Prospective, Real-World Study.

Basoulis D, Mastrogianni E, Karamanakos G, Gkoufa A, Georgakopoulou V, Makrodimitri S Viruses. 2024; 16(8).

PMID: 39205319 PMC: 11359519. DOI: 10.3390/v16081345.

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S Vaccines (Basel). 2024; 12(7).

PMID: 39066422 PMC: 11281604. DOI: 10.3390/vaccines12070784.

Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience.

Cona A, Tavelli A, Agrenzano S, Hafeez N, Scianna G, Maria A Microorganisms. 2024; 12(7).

PMID: 39065204 PMC: 11279136. DOI: 10.3390/microorganisms12071436.

Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.

Kawashiro K, Suzuki R, Nogimori T, Tsujino S, Iwahara N, Hirose T Sci Rep. 2024; 14(1):12176.

PMID: 38806644 PMC: 11133393. DOI: 10.1038/s41598-024-63147-z.